World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
79
Citations
24808
World Ranking
1633
National Ranking
752

Medicine

D-Index
82
Citations
27568
World Ranking
16007
National Ranking
8054

Hans Peter Kiem publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Hans Peter Kiem sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 505 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Hans Peter Kiem D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Hans Peter Kiem sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 79 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Hans Peter Kiem is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research spans multiple fields, predominantly in biochemistry, genetics, molecular biology, and medicine. Within these broad areas, Kiem's work focuses on molecular biology, genetics, oncology, immunology, and hematology.

Their studies have largely concentrated on topics such as CAR-T cell therapy research, virus-based gene therapy research, CRISPR and genetic engineering, RNA interference and gene delivery, immune cell function and interaction, hematopoietic stem cell transplantation, and T-cell and B-cell immunology.

Frequent publication venues for Kiem's work include Blood with 29 publications, Molecular Therapy - Methods & Clinical Development with 15, Molecular Therapy with 12, Blood Advances with 11, and Transplantation and Cellular Therapy with 6.

Some of the notable recent papers authored or co-authored by Kiem include:

  • SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues, 2020, Cell
  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021, 2021, Nature Medicine
  • Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy, 2020, Nature Communications
  • Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies, 2020, Blood
  • In vivo HSC prime editing rescues Sickle Cell Disease in a mouse model, 2023, Blood

Hans Peter Kiem collaborates frequently with several co-authors, including Stefan Radtke, David G. Maloney, Jordan Gauthier, Cameron J. Turtle, and Mazyar Shadman.

Best Publications

  • SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.

    Carly G.K. Ziegler;Samuel J. Allon;Sarah K. Nyquist;Ian M. Mbano

  • Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

    Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts

    James J.H. Chong;Xiulan Yang;Creighton W. Don;Elina Minami

  • Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

    Ingo G H Schmidt-Wolf;Robert S. Negrin;Hans Peter Kiem;Karl G. Blume

  • Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.

    Rainer Storb;Cong Yu;John L. Wagner;H. Joachim Deeg

  • Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

    Mary E D Flowers;Yoshihiro Inamoto;Paul A. Carpenter;Stephanie J. Lee

  • Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal

    Iman Fares;Jalila Chagraoui;Yves Gareau;Stéphane Gingras

  • International AIDS Society global scientific strategy: towards an HIV cure 2016

    Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich

  • Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.

    Kevin A. Hay;Kevin A. Hay;Jordan Gauthier;Alexandre V. Hirayama;Jenna M. Voutsinas

  • Improved Gene Transfer Into Baboon Marrow Repopulating Cells Using Recombinant Human Fibronectin Fragment CH-296 in Combination With Interleukin-6, Stem Cell Factor, FLT-3 Ligand, and Megakaryocyte Growth and Development Factor

    Hans Peter Kiem;Hans Peter Kiem;Robert G. Andrews;Robert G. Andrews;Julia Morris;Julia Morris;Laura Peterson;Laura Peterson

  • Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

    H. Joachim Deeg;Barry Storer;John T. Slattery;Claudio Anasetti

  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

    Steven G. Deeks;Nancie Archin;Paula Cannon;Simon Collins

  • The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.

    Alexandre V. Hirayama;Jordan Gauthier;Kevin A. Hay;Kevin A. Hay;Jenna M. Voutsinas

  • Allogeneic hematopoietic stem cell transplantation for myelofibrosis

    H. Joachim Deeg;Theodore A. Gooley;Theodore A. Gooley;Mary E D Flowers;Mary E D Flowers;George E. Sale;George E. Sale

  • Duration of immunosuppressive treatment for chronic graft-versus-host disease.

    Betty L. Stewart;Barry Storer;Jan Storek;H. Joachim Deeg

  • Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD

    Afonso C. Vigorito;Paulo V. Campregher;Barry E. Storer;Paul A. Carpenter

  • Foamy virus vector integration sites in normal human cells

    Grant D. Trobridge;Daniel G. Miller;Michael A. Jacobs;James M. Allen

  • Polyclonal long-term repopulating stem cell clones in a primate model.

    Manfred Schmidt;Manfred Schmidt;Manfred Schmidt;Philipp Zickler;Philipp Zickler;Philipp Zickler;Gesa Hoffmann;Gesa Hoffmann;Gesa Hoffmann;Sebastian Haas;Sebastian Haas;Sebastian Haas

  • Gene Transfer into Marrow Repopulating Cells: Comparison Between Amphotropic and Gibbon Ape Leukemia Virus Pseudotyped Retroviral Vectors in a Competitive Repopulation Assay in Baboons

    Hans Peter Kiem;Hans Peter Kiem;Scott Heyward;Scott Heyward;Aaron Winkler;Aaron Winkler;Jennifer Potter;Jennifer Potter

  • Survival of the fittest: in vivo selection and stem cell gene therapy.

    Tobias Neff;Brian C. Beard;Hans Peter Kiem

Frequent Co-Authors

Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
David J. Rawlings
David J. Rawlings Seattle Children's Hospital
Richard A. Nash
Richard A. Nash Fred Hutchinson Cancer Research Center
Stanley R. Riddell
Stanley R. Riddell University of Washington
Cameron J. Turtle
Cameron J. Turtle Fred Hutchinson Cancer Research Center
H. Joachim Deeg
H. Joachim Deeg Fred Hutchinson Cancer Research Center
Brenda M. Sandmaier
Brenda M. Sandmaier Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
Keith R. Jerome
Keith R. Jerome Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Understanding genetics opens the door to diverse healthcare careers, many of which require advanced education and specialized skills. For those interested in patient care or healthcare leadership, affordable online nursing degrees offer accessible pathways to rewarding careers. Students can compare the cheapest np school programs if they wish to become nurse practitioners, a role that combines clinical expertise with a deep understanding of genetics and human biology.

Accelerated programs are also available for those wanting to enter the workforce quickly. Exploring the cheapest accelerated nursing programs can help students balance financial considerations with speedy degree completion. For nurses aiming to advance into top-tier clinical or leadership positions, pursuing cheap online dnp programs can provide a cost-effective route to the highest level of nursing practice.

Additionally, registered nurses looking to enhance their credentials can benefit from cheap rn to bsn programs. These pathways not only promote career advancement but also align well with emerging trends in genomics and personalized medicine. By choosing an affordable and relevant degree, you can position yourself for success in a genetics-related healthcare field.

Best Scientists Citing Hans Peter Kiem

Trending Scientists

Recently Published Articles